Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-22

Clinical Trial Update: Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors

View source ↗

Summary

A prospective cohort trial evaluating Hepatitis C screening strategies — CDC birth-cohort recommendations versus traditional risk-factor-based screening — has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Chronic Hepatitis C Virus Infection | Status: WITHDRAWN